Allergy induced by exposure to animals 1
Man lives in close domestic contact with certain animal species, perhaps most commonly with dogs, cats and caged birds. Allergic disease resulting from this contact is well recognized.
Occupational exposure to animals is also significant and involves individuals in many different professional circumstances, for example, veterinary surgeons, biologists and other laboratory workers. The prevalence and nature of allergic disorders in this group of individuals have received increasing attention in recent years and concern has been sharply focused by the proposed inclusion of occupational asthma as a prescribed disease under The Social Security Act of 1975.
A symposium was held recently by the Section of Comparative Medicine of the Royal Society of Medicine on this topic. The membership of that Section were joined by a large gathering of individuals from a range of interests and backgrounds but mainly from those concerned with the practical problems of occupational medicine.
Prevalence studies and clinical picture Dr A Newman-Taylor, in his introductory remarks, described the clinical syndrome now known as laboratory animal allergy (LAA). He described it as an allergic disorder characterized by conjunctivitis, rhinitis, urticaria and asthma causally related to exposure to allergens derived from animals. The syndrome had the typical characteristics of an IgE antibody mediated condition. Initial fears that an extrinsic allergic alveolitis component might also be present had not been substantiated.
,Other speakers in the first session confirmed this clinical picture. Dr A Cockcroft reported that experience in three MRC units was that asthma never occurred in the absence of rhinitis (Cockcroft et al. 1981 )and, in fact, rhinitis was the commonest symptom experienced.
The prevalence of laboratory animal allergy, as presented to this symposium, is given in further statistical surveys. Notable amongst the findings were the highly significant increases in the animal worker group for asthma, nasal symptoms and eye symptoms whereas hayfever, eczema and bronchitis occurred equally amongst animal workers and non-animal workers. Thus, Dr Davies concluded that allergic reactions in animal workers were an important occupational health problem.
Immunological findings
Dr Newman-Taylor stressed the need for more detailed study of the immune response to animal allergens and of the relationship of antibody response in the different immunoglobulin classes to disease. On the basis of skin prick tests, radioallergosorbent test results and the overall clinical picture, it was reasonable to assume that IgE antibody was a major causative factor and that urine was an important SOurce of allergens (Newman-Taylor et af. 1981) .
Data on the value of skin prick tests were given by Dr R Orr who had evaluated Bencard commercial and experimental skin test solutions in staff at a research centre. He showed that prick tests using urinary allergens from rats and mice were somewhat more potent in the diagnosis of LAA than were epithelial derived allergen tests at the concentrations used. The situation with regard to guinea pig and rabbit urinary proteins was less clear and further tests were needed. Overall, prick tests were supportive of a diagnosis of LAA in 67% of cases.
A similar picture emerged from a study reported by Dr J Dewdney on specific IgE antibody in serum measured by the radioallergosorbent test (RAST). RAST, it was concluded, was of value in the diagnosis of LAA, but not all individuals with well diagnosed LAA gave a positive RAST and some individuals who experienced no symptoms and who were prick-test negative had a positive RAST. Thus RAST was positive in 64% of individuals with diagnosed, current LAA and in 50% with past LAA. It was positive also in 15%of animal workers with no clinical symptoms and in 5% of non-animal workers. It was important to establish whether these latter individuals were responding to exposure and might be at risk or whether the apparent false positive results were due to methodological problems. The conclusion overall was that, of positive RAST findings in individuals with LAA, 81% were associated with the species used and 71% were confirmed also by prick tests with the same urinary allergen preparation.
The immune response in the IgG immunoglobulin class was discussed by Dr T Platts-Mills. His results indicated a relationship between exposure and an immune response in the IgG class to a partially-purified rat-derived allergen, measured by binding assay (Chapman & Platts-Mills 1978) . Specific IgG was found in 60% of animal handlers, but in only 6% of an unexposed population. This finding could well have utility in monitoring staff for exposure. No relationship was found between IgG prevalence or titre and a clinical diagnosis of LAA.
Laboratory animal allergy and atopy
An important question which several speakers tried to answer was the relationship between atopy and susceptibility to laboratory animal allergy. Clearly this matter was of critical interest to those concerned with pre-employment medical examinations and resulting policies on employment matters.
The first difficulty arose 'in the definition of atopy. Atopy may be defined in clinical terms, that is that the patient is atopic if he shows signs of hayfever, asthma or skin disorders in response to common' aeroallergens. Atopy may also be defined in immunological terms, that is that an individual is atopic if he responds to prick tests with these allergens (Pepys 1974).
In spite of these differences in the definitions used. there was clear evidence of a close association between atopy and the development of asthma due to LAA. From figures reported to the symposium by several speakers drawing from experience in different studies (see references to Table I ), between 80-100% of those developing asthma to animal allergens were clearly atopic persons although not necessarily experiencing non-animal related asthma. This point led to detailed discussion on the wisdom and practicality of excluding atopies from work involving exposure to animals. It was agreed by speakers and discussants that to do so would very significantly reduce the number of persons who develop laboratory animal asthma but this benefit would be achieved only by excluding very large numbers of atopic persons who were unlikely to develop LAA. Such a move was, therefore, not recommended. Most felt, intuitively perhaps, that atopic asthmatics should not be employed to work with animals, but no facts supportive of this view were to hand. Association between other forms of LAA (that is rhinitis, conjunctivitis and dermatoses) and atopy was weak. As emphasized by Dr Newman-Taylor in his opening remarks and by others, this situation is somewhat surprising and further study is required. Table 2 gives an overview of data presented to the symposium. The findings give some support to a proposal put forward recently (Slovak & Hill Low~; . of sufferers positive Regional LAA 1981) that LAA occurs in two forms, regional and progressive. Further study is needed on this important issue.
Immunochemistry
Three papers were given on the immunochemistry of the allergens involved in LAA.
Dr J Longbottom described the isolation and analysis of allergens in the urines of rats and mice. Electrophoretic analysis had indicated that over 90% of the protein in mouse urine was a prealbumin component whereas in rat urine there were many protein components, including serum proteins (particularly serum albumin) and two distinct urinary proteins in the 1X 2-globulin and pre-albumin regions. Separation of the proteins by column chromatography showed these specific urinary proteins to be the most skin-reactive constituents and their allergenicity was confirmed using the crossed radioimmunoelectrophoretic technique (CRIE). Further characterization showed them to be antigenically partially identical components, each existing in several isoallergenic fonns with molecular weights in the range of 12000-20000 daltons. The 1X2-globulin component was shown to be present in kidney and liver, whereas the pre-albumin had been identified in saliva, dander and in the dust (1-4 mg/g dry weight) and in air samples (37 ng/rrr') of rat rooms.
Dr D Stanworth, in his introductory and summing up remarks for this session, drew attention to the discriminatory powers of modern protein separation and analytical techniques but cautioned that, while these were of value in determining cross-antigenicity between components, there might be a tendency for isoantigens to be regarded as unique components. All allergenic components were required in any diagnostic or therapeutic solutions which might be prepared.
. In referring to his own, now classic, studies on horse dander allergens, he commented how even with the techniques available some twenty-five years ago, it had proved possible to identify the major allergens. Characterization of the horse dander allergen revealed it to have properties now known to be generally applicable for allergens: relatively low MW, robust molecules, acidic in nature.
Dr H Lowenstein broadened the topic further by discussion of the methodology and conclusions to be drawn from a study of epithelial allergens derived from other animal species, the horse, cow, dog and cat. He stressed the value ofCRIE in the identification of allergens in complex protein mixtures; it allowed compilation of allergograms from which major allergens could be identified. The number of major allergens varied from species to species. Thus, there were four in the cow, three in the dog and horse, and only one in the cat. In the horse, albumin was only a very minor allergen, whereas in the dog and cat it proved to be a more important allergen and responsible, together with the (-globulin components, for cross-allergenicity between dogs and cats. An analysis of breed differences amongst dogs revealed that there were no breed-specific allergens, only quantitative differences in the various allergens present.
In view of the complexity of the allergens derived from animals, whether of serum, urinary or epithelial origin, attention would have to be paid in the future to the standardization of any materials to be given to man, in therapy or in diagnosis. If therapy were to be considered it would be necessary also to establish whether a simple correlation exists between the ability of molecules to bind specific IgE and the efficacy of treating patients with the corresponding allergens.
Management and control
Dr C Pickering, in introducing the session on management and control of LAA, drew attention to the possible incidence of LAA and of laboratory animal asthma. There might be some 4700-8600 cases of LAA and 2400-3700 laboratory animal asthmatics in the UK; inclusion of laboratory animal asthma as a prescribed disease was, therefore justified. He added that removal of an LAA sufferer from the workplace resulted in a fairly rapid recovery.
Dr A Slovak analysed the value of several diagnostic procedures· and recommended that evaluation of the LAA individual should include detailed questionnaire and medical history, and the use of individual mini-Wright flow meters every two hours over a period of months to detect real changes in lung function. In his experience spirometric measurements taken before and after shift working were not helpful. Prick testing was useful for diagnosis only in individuals with asthma due to laboratory animal allergy (see Table 2 ).
Several aspects of management were described. Whilst relocation might be the preferred action in relation to an employee who developed LAA, many could continue working if provided with adequate personal protection, for example, masks, airstream helmets, gloves and gowns. Wherever possible, work should be done in a work station or other safety cabinet. The possibility of therapy of' LAA was not addressed in any detail. It was felt to be largely inappropriate for a condition best controlled by avoidance of exposure to the eliciting allergens. However, Dr Pickering and Dr Slovak reported that drugs of the disodium cromoglycate type could be of value in certain circumstances (Gross 1980) . Dr Lutsky questioned the speakers on the role of immunotherapy. There was a report of the efficacy of this form of treatment (Wahn & Siraganian 1980) but none of the clinicians present had any personal experience of it. It was suggested that any such therapy would have to be approached cautiously and based on well characterized and standardized allergens. Circumstances were somewhat different from other allergic diseases, for example, hay fever, where levels of specific IgG antibodies in untreated individuals were very significantly lower and the allergen challenge also much lower.
Dr Slovak thought that attention should also be paid to caging systems, segregation of animals and workers and to the hazards which could be created by the transportation of animals, for example, through laboratories and corridors in open cages. Finally, he thought that effort should be made to try to define acceptable levels of airborne allergens, although he anticipated that acceptable threshold levels from a clinical point of view might be impracticable in everyday situations.
Aeroenvironmental control
Dr G Burrows developed the question of threshold values further. Based on his experience in subjecting a number of volunteers with LAA to various airflow patterns in an experimental animal room, he concluded that if the number of particles > 0.511 did not exceed 2000 particles per cubic foot (ppcf) then all but the most sensitive could remain in the environment without clinical symptoms. Dr Burrows' conclusions were based on particle counts, not on allergen content.
The methods for measuring urinary allergens in the environment had been established and were reported by Dr R Edwards. Airborne allergens were collected using Casella Simquad samplers with O' 511 glass fibre filters. The resulting allergens were eluted from the filters and assayed using a RAST inhibition technique. Levels of 60 ng/rrr' of air were detected in a mouse holding room and some 316 ng/m'' from a filter placed near an extraction air duct of the room. Corridors outside the room had lower levels of aeroallergens derived from animal urines and were of the order of 10 ng/rrr'. Dr Edwards concluded that the technique could be used to monitor airborne allergens and the efficiency of airflow systems.
Dr A Longworth presented an engineer's approach to control of the aeroenvironment. He pointed out that airflows must be tailored to individual circumstances. Changes in stocking levels and the activity of animals markedly influenced the concentration of particles of dust in the room. Even in the presence of forced ventilation, convection currents generated by the body heat of the animals impose a significant stirring of room air.
Nonetheless, some attempts had been made to reduce airborne particles by altering the patterns of room air flow and changing the number of air changes per hour. The ppcf varied inversely with the total volumetric throughput of air per animal. In studies reported by Dr Burrows, the reduction to 2000 ppcf noted above was achieved only by increasing air flow to 2·5 cubic feet per minute (cfm) per animal, equivalent in that test room to sixty air changes per hour, an expensive procedure which might not be in the interest of good animal husbandry, as pointed out by Dr Warren of the Home Office Inspectorate. Nevertheless, this rate was considerably less than in 'laminar' air flow rooms, and with only 50% recirculation after absolute filtration it provided a high degree of dilution of ammonia and other gases with fresh outdoor air.
Clearly, the whole topic of animal house monitoring required much further study but it was encouraging that clinicians, scientists and engineers were now collaborating in this important aspect of LAA.
Legal aspects
In the final session, Dr R Murray outlined employers' responsibilities under the Health and Safety at Work Act and under Common Law. In general terms it was the employer's responsibility to take all reasonable precautions to safeguard the health of his employees. The White Paper, which was a report from the Industrial Diseases Sub-Committee of the Industrial Injuries Advisory Council (1981) , recommended that occupational asthma should be made a prescribed disease under the Social Security Act 1975. The main consequence of this recommendation was that persons developing asthma caused by occupational exposure to laboratory animals . would be compensated by Government in the form of disablement benefit payments and some recompense for loss of earnings if the individual had to be relocated to a post of lower remuneration. Dr Murray reminded the audience that a similar situation existed for allergic contact dermatitis (Prescribed Disease No. 42 of the Industrial Injuries Provisions of the Social Security Act 1975) and for nasal mucosal inflammation under which category allergic rhinitis would fall (Prescribed Disease No. 41 of the Industrial Injuries Provisions of the Social Security Act 1975).
Discussion from the floor indicated that employers might not be clear what their responsibilities in this matter were. Dr Murray advised that an employer should not enforce relocation following a diagnosis of LAA if this were contrary to the employee's wishes. The employer should, however, obtain written evidence that the employee had had the risks fully explained to him. Although it was not demanded of him by law, an employer should demonstrate his concern and responsibilities by instituting some form of medical surveillance of staff potentially at risk and possibly also by allergen monitoring of the environment. Prevention was clearly better than remedial action and employers should endeavour to provide conditions, whether environmental or by way of personal protection, to minimize risk to staff. Questions of medical ethics were debated.
